Wed, May 18, 2022
Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022
Thu, May 12, 2022

Ed Arce Maintained (AKBA) at Hold with Decreased Target to $1.25 on, May 16th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. h-decreased-target-to-1-25-on-may-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Hold with Decreased Target from $2 to $1.25 on, May 16th, 2022.

Ed has made no other calls on AKBA in the last 4 months.



There are 3 other peers that have a rating on AKBA. Out of the 3 peers that are also analyzing AKBA, all agree with Ed's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, March 31st, 2022
  • Difei Yang of "Mizuho" Downgraded from Strong Buy to Hold and Decreased Target to $2 on, Thursday, March 31st, 2022
  • Serge Belanger of "Needham" Downgraded from Strong Buy to Hold on, Thursday, March 31st, 2022

Publication Contributing Sources